Related Experiment Video
Updated: Jan 15, 2026
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Introduction of DNA-HPV test in the Brazilian cervical cancer screening program: When the idea is good but does not
Felipe Polido Urbano1, Gabriel Russo Cury1, Caio Rodrigo Dos Santos1
1Pathology Department, Medical School, Salesian Catholic University Center Auxilium (UNISALESIANO), Araçatuba, São Paulo, Brazil.
Objective:
To evaluate the financial applicability of the DNA-HPV test for cervical cancer screening in a developing country like Brazil.
Methods:
This was a retrospective, observational study based on documentary data, conducted to assess the cost-effectiveness of cervical cancer screening strategies in Brazil. The study used national cervical cancer screening data collected between January 1 and December 31, 2020 for women between 25 and 64 years old, performing a cost-effectiveness assessment of two different screening tests. No sensitivity analysis was conducted due to the descriptive nature of this preliminary cost assessment.
Results:
Based on the cervical smear, the Brazilian protocol has an estimated cost of US$117.5 million. In contrast, when using the HPV DNA test, the estimated cost is US$1.39 billion.
Conclusion:
The current use of the cervical smear is the least expensive and the only one that aligns with Brazil's financial resources allocated to health.
More Related Videos
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Related Concept Videos
02:59Cancer Prevention
Some...
00:55DNA Helicases